American Century Investment Management, Inc., American Century Companies, Inc. and Stowers Institute for Medical Research report beneficial ownership of IBEX Limited common stock. Each reports beneficial ownership of 510,633 shares, representing 3.8% of the class as of June 30, 2026.
The reporting persons have sole voting power and sole dispositive power over these 510,633 shares, with no shared voting or dispositive power. The shares are held for various clients advised by American Century Investment Management, Inc., and no single client beneficially owns more than 5% of the class.
IBEX Ltd director Fiona Elizabeth Beck acquired 1,252 Common Shares on July 31, 2026 through performance-based stock units earned upon certification of performance goals for the period ending June 30, 2026. Following this award, she directly holds 14,835 Common Shares.
IBEX Ltd director Zhuang Mingzhe acquired 1,252 Common Shares on July 31, 2026 through the earning and conversion of performance-based stock units. These PSUs were earned when performance goals for the period ending June 30, 2026 were certified. After this equity award, Zhuang directly holds 8,335 Common Shares, reflecting compensation rather than an open-market purchase or sale.
IBEX Ltd director John William Jones acquired 1,353 Common Shares on July 31, 2026 at no cost, when previously granted performance-based stock units were earned upon certification of performance goals for the period ending June 30, 2026. After this conversion, he directly holds 16,597 Common Shares.
IBEX Ltd executive Bruce Neil Dawson, Chief Sales and CS Officer, earned and acquired 1,954 performance-based stock units that converted into Common shares on July 31, 2026 after performance for the period ending June 30, 2026 was certified. To satisfy related taxes, 855 shares were withheld by the company at $35.34 per share; no shares were sold by him to cover this tax liability.
IBEX Ltd reports that Chief Financial Officer Greenwald Taylor C acquired 3,307 Common Shares on July 31, 2026 when performance-based stock units were earned for the period ending June 30, 2026 and converted to stock. On the same date, 956 shares were withheld to satisfy tax liability at 35.3400 per share; no shares were sold into the market.
IBEX Ltd reports that Chief People Officer Paul Joseph Inson earned and acquired 2,405 Common Shares on July 31, 2026, when performance-based stock units were certified for the period ending June 30, 2026 and converted to shares. To cover related taxes, the issuer withheld 1,053 shares valued at $35.34 per share; no shares were sold into the market.
IBEX Ltd director Karen Batungbacal reported an equity compensation award. On July 31, 2026, 1,252 performance-based stock units (PSUs) were earned upon certification of performance goals for the period ending June 30, 2026 and converted into Common Shares, increasing her direct holdings to 8,335 shares.
IBEX Ltd director Patrick McGinnis reported an equity award. On July 31, 2026, he acquired 1,252 Common Shares when an equal number of performance-based stock units (PSUs) were earned after certification of performance goals for the period ending June 30, 2026 and converted into shares. Following this non-market award, he holds 7,085 Common Shares directly.
IBEX Ltd director Daniella Ballou-Aares reported the acquisition of 1,252 common shares on July 31, 2026. These shares were earned as performance-based stock units after certification of performance goals for the period ending June 30, 2026 and converted to common shares. Following this award, she holds 11,895 shares directly.